| Literature DB >> 17354169 |
Ninoska Flores1, Gabriela Cabrera, Ignacio A Jiménez, Jose Piñero, Alberto Giménez, Genevieve Bourdy, Fernando Cortés-Selva, Isabel L Bazzocchi.
Abstract
The kavapyrone (+)-(7 R,8 S)-epoxy-5,6-didehydrokavain (1) and the chalcone flavokavain B (2) were isolated from Piper rusbyi as the bioactive components by bioassay-guided fractionation, using an in vitro assay against promastigote forms of three Leishmania strains. In addition, the new kavapyrone, (7 R,8 R/7 S,8 S)-dihydroxy-5,6-didehydrokavain (3), which is very likely an artifact, and four known compounds (4-7) were isolated. Their structures were elucidated on the basis of spectral analysis, and the absolute configurations of compounds 1 and 3 were established by CD studies and the modified Mosher ester procedure, respectively. All compounds were evaluated for in vitro leishmanicidal activity. The most active compounds 1 (IC50=81.9 microM) and 2 (IC50=11.2 microM) were also evaluated in vivo against a New World strain of cutaneous leishmaniasis, and the results showed the efficacy of 2 at a dose of 5 mg/kg/day. Compounds 1 and 3 were also assayed as reversal agents against a multidrug-resistant Leishmania tropica line, but were found to be inactive.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17354169 DOI: 10.1055/s-2007-967123
Source DB: PubMed Journal: Planta Med ISSN: 0032-0943 Impact factor: 3.352